PSYB Leo Acquisitions Corp.

Leo Acquisitions Enters into Binding Letter of Intent for Qualifying Transaction with PsyBio Therapeutics

Leo Acquisitions Enters into Binding Letter of Intent for Qualifying Transaction with PsyBio Therapeutics
EN
05/10/2020

Underlying

PSYBLeo Acquisitions Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Leo Acquisitions Corp.

 PRESS RELEASE
Free
PSYB Leo Acquisition...

Leo Acquisitions Announces Filing of Filing Statement in Connection Wi...

Leo Acquisitions Announces Filing of Filing Statement in Connection With Qualifying Transaction Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (NEX: LEQ.H) (“Leo” or the “Company”) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the “TSXV”) for its previously announced Qualifying Transaction (as defined in TSXV Policy 2.4) (the “Trans...

February 17, 2021 1 EN
 PRESS RELEASE
Free
PSYB Leo Acquisition...

PsyBio Therapeutics and Leo Acquisitions Announce Closing of CAD$14.5 ...

PsyBio Therapeutics and Leo Acquisitions Announce Closing of CAD$14.5 Million Oversubscribed Private Placement Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- PsyBio Therapeutics, Inc. (“PsyBio”) and Leo Acquisitions Corp. (NEX: LEQ.H) (“Leo” or the “Company”) are pleased to announce the closing of the previously announced brokered private placement (the “Financing”) of subscription receipts (the “Subscri...

December 4, 2020 1 EN
 PRESS RELEASE
Free
PSYB Leo Acquisition...

PsyBio Therapeutics and Leo Acquisitions Announce Entering Into of Def...

PsyBio Therapeutics and Leo Acquisitions Announce Entering Into of Definitive Agreement for Qualifying Transaction and Upsized Private Placement Financing Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- PsyBio Therapeutics, Inc. (“PsyBio”) and Leo Acquisitions Corp. (NEX:LEQ.H) (“Leo” or the “Company”) are pleased to provide an update on their previously announced proposed qualifying transaction on the T...

December 3, 2020 1 EN
 PRESS RELEASE
Free
PSYB Leo Acquisition...

Leo Acquisitions and PsyBio Therapeutics Announce the Engagement of Ei...

Leo Acquisitions and PsyBio Therapeutics Announce the Engagement of Eight Capital as Lead Agent for Private Placement of approximately $5 million Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Leo Acquisitions Corp. (TSXV: LEQ.H) (“Leo” or the “Company”) and PsyBio Therapeutics, Inc. (“PsyBio”) are pleased to provide an update on their previously announced proposed qualifying transaction (the “Transaction”) on the TSX Venture Exchange (the “Exchange”).  All references to dollar amounts in this ...

October 26, 2020 1 EN
 PRESS RELEASE
Free
PSYB Leo Acquisition...

Leo Acquisitions Enters into Binding Letter of Intent for Qualifying T...

Leo Acquisitions Enters into Binding Letter of Intent for Qualifying Transaction with PsyBio Therapeutics

October 5, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch